Clinical Trials in Baltimore

Showing 2481-2500 of 20,142 trials

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

NCT04634513

The purpose of this study is to determine whether a live, oral, combined Shigella-ETEC vaccine candidate, known as strain CVD 1208S-122, is safe and immunogenic.

Shigella InfectionEnterotoxigenic Escherichia Coli Infection

University of Maryland, Baltimore53 participantsStarted Sep 2022

Baltimore, Maryland, United States

Active Not RecruitingPhase 2< 1 mile

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

NCT01511562

The purpose of this study is to find out what effects (good and/or bad) treatment with chemotherapy and stem cell transplant compared with chemotherapy alone will have on primary CNS B-cell lymphoma. Currently the best treatment for patients with primary CNS B-cell lymphoma is not known.

Lymphoma

Alliance for Clinical Trials in Oncology113 participantsStarted Sep 2012

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +123 more locations

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Find Trials by Condition in Baltimore

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

The DC Cohort Longitudinal HIV Status Neutral Study

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.

Abbott Structural Heart Device Registry

GDNF Gene Therapy for Multiple System Atrophy

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

Gene Transfer Study in Patients With Late Onset Pompe Disease